Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Development of an inhibitor in a child with severe hemophilia B: treatment with immunosuppression and an extended desensitization protocol.

Roberts JC, Jesudas R, Tarantino MD.

Blood Coagul Fibrinolysis. 2019 Sep;30(6):291-294. doi: 10.1097/MBC.0000000000000829.

PMID:
31259775
2.

Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.

Tarantino MD, Bussel JB, Blanchette VS, Beam D, Roy J, Despotovic J, Raj A, Carpenter N, Mehta B, Eisen M.

Haematologica. 2019 Nov;104(11):2283-2291. doi: 10.3324/haematol.2018.202283. Epub 2019 Mar 7.

3.

Central venous access device catheter fragmentation at time of removal in four patients with haemophilia A.

White S, Jesudas R, Brady TM, Tarantino MD.

Haemophilia. 2019 May;25(3):e185-e188. doi: 10.1111/hae.13708. Epub 2019 Feb 28. No abstract available.

PMID:
30817053
4.

Synthetic Cannabinoid-Associated Coagulopathy.

Kelkar AH, Tarantino MD, Roberts JC.

N Engl J Med. 2019 Jan 3;380(1):101-102. doi: 10.1056/NEJMc1814118. No abstract available.

PMID:
30601754
5.

An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois.

Kelkar AH, Smith NA, Martial A, Moole H, Tarantino MD, Roberts JC.

N Engl J Med. 2018 Sep 27;379(13):1216-1223. doi: 10.1056/NEJMoa1807652.

6.

Risk factors associated with intraventricular hemorrhage in extremely premature neonates.

Roberts JC, Javed MJ, Hocker JR, Wang H, Tarantino MD.

Blood Coagul Fibrinolysis. 2018 Jan;29(1):25-29. doi: 10.1097/MBC.0000000000000661.

PMID:
28901997
7.

Radionuclide synovectomy/synoviorthesis (RS) in patients with bleeding disorders: A review of patient and procedure demographics and functional outcomes in the ATHNdataset.

McGuinn C, Cheng D, Aschman D, Carpenter SL, Sidonio R, Soni A, Tarantino MD, Wheeler AP, Dunn AL; ATHN3 Working Group.

Haemophilia. 2017 Nov;23(6):926-933. doi: 10.1111/hae.13318. Epub 2017 Aug 24.

PMID:
28838029
8.

Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disorders.

Chitlur M, Rajpurkar M, Recht M, Tarantino MD, Yee DL, Cooper DL, Gunawardena S.

Int J Gen Med. 2017 Apr 3;10:95-99. doi: 10.2147/IJGM.S128953. eCollection 2017.

9.

Hemophilia Management via Data Collection and Reporting: Initial Findings from the Comprehensive Care Sustainability Collaborative.

Tarantino MD, Pindolia VK.

J Manag Care Spec Pharm. 2017 Jan;23(1):51-56. doi: 10.18553/jmcp.2017.23.1.51.

10.

Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients.

Tarantino MD, Cuker A, Hardesty B, Roberts JC, Sholzberg M.

Haemophilia. 2017 Jan;23(1):25-32. doi: 10.1111/hae.13040. Epub 2016 Aug 10.

PMID:
27511890
11.

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.

Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C, Raj A, Williams B, Beam D, Morales J, Rose MJ, Carpenter N, Nie K, Eisen M.

Lancet. 2016 Jul 2;388(10039):45-54. doi: 10.1016/S0140-6736(16)00279-8. Epub 2016 Apr 18.

PMID:
27103127
12.

Hospitalizations in pediatric patients with immune thrombocytopenia in the United States.

Tarantino MD, Danese M, Klaassen RJ, Duryea J, Eisen M, Bussel J.

Platelets. 2016 Jul;27(5):472-8. doi: 10.3109/09537104.2016.1143923. Epub 2016 Mar 4.

13.

Romiplostim as a treatment for immune thrombocytopenia: a review.

Chalmers S, Tarantino MD.

J Blood Med. 2015 Jan 19;6:37-44. doi: 10.2147/JBM.S47240. eCollection 2015. Review.

14.

Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.

Boylan B, Rice AS, Dunn AL, Tarantino MD, Brettler DB, Barrett JC, Miller CH; Hemophilia Inhibitor Research Study Investigators; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2015 Jan;13(1):47-53. doi: 10.1111/jth.12768. Epub 2014 Dec 11.

15.

Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.

Tarantino MD, Fogarty PF, Shah P, Brainsky A.

Platelets. 2015;26(1):93-6. doi: 10.3109/09537104.2013.870333. Epub 2014 Jan 16.

PMID:
24433306
16.

Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia.

Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A.

Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99.

PMID:
23492914
17.

Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag.

Tarantino MD, Bakshi KK, Brainsky A.

Platelets. 2014;25(1):55-61. doi: 10.3109/09537104.2013.764980. Epub 2013 Feb 12.

18.

Progressing towards optimal management of haemophilia A patients with inhibitors. Foreword.

Tarantino MD.

Haemophilia. 2013 Jan;19 Suppl 1:1. doi: 10.1111/hae.12048. No abstract available.

PMID:
23278992
19.

The impact of the economic downturn and health care reform on treatment decisions for haemophilia A: patient, caregiver and health care provider perspectives.

Tarantino MD, Ye X, Bergstrom F, Skorija K, Luo MP.

Haemophilia. 2013 Jan;19(1):51-8. doi: 10.1111/hae.12008. Epub 2012 Sep 25.

PMID:
23004924
20.

Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia.

Fogarty PF, Tarantino MD, Brainsky A, Signorovitch J, Grotzinger KM.

Curr Med Res Opin. 2012 Jan;28(1):79-87. doi: 10.1185/03007995.2011.644849. Epub 2011 Dec 20.

PMID:
22117897
21.

Healthcare resource utilization among haemophilia A patients in the United States.

Valentino LA, Pipe SW, Tarantino MD, Ye X, Xiong Y, Luo MP.

Haemophilia. 2012 May;18(3):332-8. doi: 10.1111/j.1365-2516.2011.02677.x. Epub 2011 Nov 2.

PMID:
22044662
22.

RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).

Despotovic JM, Lambert MP, Herman JH, Gernsheimer TB, McCrae KR, Tarantino MD, Bussel JB.

Transfusion. 2012 May;52(5):1126-36; quiz 1125. doi: 10.1111/j.1537-2995.2011.03384.x. Epub 2011 Oct 7. Review.

23.

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).

Gernsheimer TB, George JN, Aledort LM, Tarantino MD, Sunkara U, Matthew Guo D, Nichol JL.

J Thromb Haemost. 2010 Jun;8(6):1372-82. doi: 10.1111/j.1538-7836.2010.03830.x. Epub 2010 Mar 3.

24.

Impact of ITP on physician visits and workplace productivity.

Tarantino MD, Mathias SD, Snyder CF, Isitt JJ, Gernsheimer T, Young J.

Curr Med Res Opin. 2010 Feb;26(2):319-28. doi: 10.1185/03007990903451298.

PMID:
19968458
25.

Bivalirudin for anticoagulation in children.

Rayapudi S, Torres A Jr, Deshpande GG, Ross MP, Wohrley JD, Young G, Tarantino MD.

Pediatr Blood Cancer. 2008 Dec;51(6):798-801. doi: 10.1002/pbc.21731.

PMID:
18819124
26.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL.

Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2.

PMID:
18242413
27.

Update on the management of immune thrombocytopenic purpura in children.

Tarantino MD, Bolton-Maggs PH.

Curr Opin Hematol. 2007 Sep;14(5):526-34. Review.

PMID:
17934363
28.

Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis.

Young G, Tarantino MD, Wohrley J, Weber LC, Belvedere M, Nugent DJ.

J Thromb Haemost. 2007 Aug;5(8):1654-9.

29.
30.

A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).

Tarantino MD, Bussel JB, Cines DB, McCrae KR, Gernsheimer T, Liebman HA, Wong WY, Kulkarni R, Grabowski E, McMillan R.

Blood. 2007 Jun 15;109(12):5527; author reply 5528. No abstract available.

PMID:
17554071
31.

Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.

Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ; Acute ITP Study Group.

J Pediatr. 2006 Apr;148(4):489-94.

PMID:
16647411
32.

The treatment of immune thrombocytopenic purpura in children.

Tarantino MD.

Curr Hematol Rep. 2006 Mar;5(1):89-94. Review.

PMID:
16537052
33.

Advances in clotting factor treatment for congenital hemorrhagic disorders.

Tarantino MD, Aledort LM.

Clin Adv Hematol Oncol. 2004 Jun;2(6):363-8. Review.

PMID:
16163206
34.

Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura.

Pratt EL, Tarantino MD, Wagner D, Hirsch Pescovitz O, Bowyer S, Shapiro AD.

Am J Hematol. 2005 Jul;79(3):175-9.

35.

The pros and cons of drug therapy for immune thrombocytopenic purpura in children.

Tarantino MD, Buchanan GR.

Hematol Oncol Clin North Am. 2004 Dec;18(6):1301-14, viii. Review.

PMID:
15511617
36.

Consensus recommendations for use of central venous access devices in haemophilia.

Ewenstein BM, Valentino LA, Journeycake JM, Tarantino MD, Shapiro AD, Blanchette VS, Hoots WK, Buchanan GR, Manco-Johnson MJ, Rivard GE, Miller KL, Geraghty S, Maahs JA, Stuart R, Dunham T, Navickis RJ.

Haemophilia. 2004 Sep;10(5):629-48. Review.

PMID:
15357790
37.

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.

Tarantino MD, Collins PW, Hay CR, Shapiro AD, Gruppo RA, Berntorp E, Bray GL, Tonetta SA, Schroth PC, Retzios AD, Rogy SS, Sensel MG, Ewenstein BM; RAHF-PFM Clinical Study Group.

Haemophilia. 2004 Sep;10(5):428-37.

PMID:
15357767
38.

Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12-18, 2003, Birmingham, UK.

Ewenstein BM, Collins P, Tarantino MD, Negrier C, Blanchette V, Shapiro AD, Baker D, Spotts G, Sensel M, Yi SE, Gomperts ED.

Semin Hematol. 2004 Jan;41(1 Suppl 2):1-16; discussion 16-8.

PMID:
15071785
39.

The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology.

Bolton-Maggs P, Tarantino MD, Buchanan GR, Bussel JB, George JN; American Society of Pediatric Hematology/Oncology.

J Pediatr Hematol Oncol. 2004 Feb;26(2):146-51.

PMID:
14767210
40.

Surveillance of infectious complications associated with central venous access devices in children with haemophilia.

Tarantino MD, Lail A, Donfield SM, Lynn H, Peddle L, Hunsberger S, Shapiro AD.

Haemophilia. 2003 Sep;9(5):588-92.

PMID:
14511299
41.

Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study.

Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T, Nugent DJ.

J Thromb Haemost. 2003 May;1(5):958-62.

42.

Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept.

McMinn JR Jr, Cohen S, Moore J, Lilly S, Parkhurst J, Tarantino MD, Terrell DR, George JN.

Am J Hematol. 2003 Jun;73(2):135-40.

43.

Acute immune (idiopathic) thrombocytopenic purpura in childhood.

Tarantino MD.

Blood Rev. 2002 Mar;16(1):19-21. Review.

PMID:
11913988
44.
45.

On the conservative management of acute immune thrombocytopenia in children.

Tarantino MD.

J Pediatr. 2001 May;138(5):787-8. No abstract available.

PMID:
11343071
46.

Allele-dependent transcriptional regulation of the human integrin alpha2 gene.

Jacquelin B, Tarantino MD, Kritzik M, Rozenshteyn D, Koziol JA, Nurden AT, Kunicki TJ.

Blood. 2001 Mar 15;97(6):1721-6.

PMID:
11238113
47.

Treatment options for chronic immune (idiopathic) thrombocytopenia purpura in children.

Tarantino MD.

Semin Hematol. 2000 Jan;37(1 Suppl 1):35-41. Review.

PMID:
10676923
48.

A novel and de novo spontaneous point mutation (Glu271STOP) of the antithrombin gene results in a type I deficiency and thrombophilia.

Tarantino MD, Curtis SM, Johnson GS, Waye JS, Blajchman MA.

Am J Hematol. 1999 Feb;60(2):126-9.

49.

Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.

Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ.

J Pediatr. 1999 Jan;134(1):21-6.

PMID:
9880444
50.

Treatment of acute immune thrombocytopenic purpura.

Tarantino MD, Goldsmith G.

Semin Hematol. 1998 Jan;35(1 Suppl 1):28-35. Review.

PMID:
9523747

Supplemental Content

Loading ...
Support Center